lovastatin and Smith-Lemli-Opitz Syndrome
lovastatin has been researched along with Smith-Lemli-Opitz Syndrome in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Beachy, PA; Cooper, MK; Gong, R; Kelley, RI; Krakowiak, PA; Porter, FD; Taipale, J; Wassif, CA | 1 |
Chen, TS; Ness, GC; Salen, G; Salen, L; Shefer, S; Tint, GS; Xu, G; Zhao, Z | 1 |
de Jong, J; Jira, P; Rubio-Gozalbo, E; Smeitink, J; Wevers, R | 1 |
Other Studies
3 other study(ies) available for lovastatin and Smith-Lemli-Opitz Syndrome
Article | Year |
---|---|
A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis.
Topics: 3T3 Cells; Animals; Anticholesteremic Agents; Cells, Cultured; Chick Embryo; Cholesterol; Cyclodextrins; Dose-Response Relationship, Drug; Hedgehog Proteins; Humans; Lovastatin; Mice; Models, Biological; Precipitin Tests; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Smith-Lemli-Opitz Syndrome; Smoothened Receptor; Time Factors; Trans-Activators; Transfection | 2003 |
Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766.
Topics: Acyl Coenzyme A; Animals; Cholesterol; Cholic Acid; Cholic Acids; Dehydrocholesterols; Disease Models, Animal; Liver; Lovastatin; Male; Microsomes, Liver; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Piperazines; Rats; Rats, Sprague-Dawley; Smith-Lemli-Opitz Syndrome | 1995 |
New treatment strategy for Smith-Lemli-Opitz syndrome.
Topics: Anticholesteremic Agents; Dehydrocholesterols; Enzyme Inhibitors; Exchange Transfusion, Whole Blood; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant; Lovastatin; Simvastatin; Smith-Lemli-Opitz Syndrome | 1997 |